Insulet (PODD) Change in Account Payables (2020 - 2026)
Insulet's (PODD) quarterly Change in Account Payables came in at $71.4 million in Q1 2026, up 95.62% YoY from $36.5 million in Q1 2025, and up 202.54% on a QoQ basis from $23.6 million in Q4 2025.
Insulet (PODD) Change in Account Payables (2020 - 2026) Analysis & Trends
Insulet (PODD) has 7 years of Change in Account Payables data on file, last reported at $71.4 million in Q1 2026.
- Quarterly Change in Account Payables rose 95.62% year-over-year to $71.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $84.1 million (up 600.6% YoY) and the FY2025 annual result came in at $49.2 million, up 2136.36% from the prior year.
- Change in Account Payables grew to $71.4 million in Q1 2026, from $23.6 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $71.4 million in Q1 2026 to a low of -$52.5 million in Q4 2023.
- A 5-year average of $6.4 million and a median of $5.4 million in 2022 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2023 — Change in Account Payables sank 1131.25% — and 2025, when it soared 3911.11%.
- Tracing PODD's Change in Account Payables over 5 years: stood at -$25.7 million in 2022, then sank by 104.28% to -$52.5 million in 2023, then jumped by 66.1% to -$17.8 million in 2024, then jumped by 232.58% to $23.6 million in 2025, then soared by 202.54% to $71.4 million in 2026.
- The last three Change in Account Payables figures came in at $71.4 million (Q1 2026), $23.6 million (Q4 2025), and -$47.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | - |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Insulet | 10.35 Bn | 9.82 Bn | 562.60 Mn | -31.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -31.50 Mn |
| Jun 30, 2026 | -31.50 Mn |
| Mar 31, 2026 | 71.40 Mn |
| Mar 31, 2026 | 71.40 Mn |
| Dec 31, 2025 | 23.60 Mn |
| Dec 31, 2025 | 23.60 Mn |
| Sep 30, 2025 | -47.00 Mn |
| Sep 30, 2025 | -47.00 Mn |
| Jun 30, 2025 | 36.10 Mn |
| Jun 30, 2025 | 36.10 Mn |
| Mar 31, 2025 | 36.50 Mn |
| Mar 31, 2025 | 36.50 Mn |
| Dec 31, 2024 | -17.80 Mn |
| Dec 31, 2024 | -17.80 Mn |
| Sep 30, 2024 | -36.40 Mn |
| Sep 30, 2024 | -36.40 Mn |
| Jun 30, 2024 | 900,000.00 |
| Jun 30, 2024 | 900,000.00 |
| Mar 31, 2024 | 55.50 Mn |
| Mar 31, 2024 | 55.50 Mn |